Shiseido Shares Tumble as Worsening China Business Prompts Guidance Cut
By Kosaku Narioka
Shiseido shares fell sharply after it cut its earnings guidance for 2023 due partly to a worsening of its business in China.
Shares were recently 14% lower at 4,191 yen on Monday morning.
Shiseido said after Friday's market close that it projects net profit to drop 47% to Y18.00 billion ($118.8 million) this year, down from its previous forecast of Y28.00 billion, and revenue to fall 8.2% to Y980.00 billion, down from Y1.000 trillion expected previously.
The Japanese cosmetics maker said its business had been weak in China and its duty-free stores as retailers cleared their inventory. It said the economic sentiment in China has deteriorated, and Chinese consumers have pulled back on purchases of Japanese products after Japan's discharge of wastewater from the Fukushima Daiichi nuclear plant in late August. Shiseido said it will book Y6.0 billion of impairment losses from the restructuring of its plant operations in Osaka this year.
For the nine months ended September, net profit dropped 29% from a year earlier to Y20.52 billion and revenue declined 5.3% to Y722.42 billion.
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
November 12, 2023 22:04 ET (03:04 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track